Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad
14h
Axios on MSNWegovy and Ozempic stars dim amid overuse concernsThe luster is starting to wear off GLP-1 weight-loss drugs including Wegovy and Ozempic as more clinicians warn patients ...
Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...
Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as ...
Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...
Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...
Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid ...
Here is more information on Wegovy, how to decide if it’s right for you, and what you need to know about the Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results